UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
TSBX holding history
Turnstone Biologics Corp. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSBX overviewAll 13F holders of TSBXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −71−100.0% | Sold out | Holders |
| Q2 2025 | 71 | $25 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 71 | $29 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 71 | $35 | <0.1% | −10,572−99.3% | Reduced | Holders |
| Q3 2024 | 10,643 | $5.93K | <0.1% | +9,092+586.2% | Added | Holders |
| Q2 2024 | 1,551 | $4.06K | <0.1% | −17,506−91.9% | Reduced | Holders |
| Q1 2024 | 19,057 | $49.9K | <0.1% | +11,886+165.8% | Added | Holders |
| Q4 2023 | 7,171 | $18.3K | <0.1% | +5,800+423.0% | Added | Holders |
| Q3 2023 | 1,371 | $5.40K | <0.1% | +1,371 | New | Holders |